|
Helbling, B. (2009). Quality of life (HRQOL) in patients with hepatitis C. In 1st International Symposium on Hepatitis care in substance users (37). Zurich: Stadt Zürich, Stadtspital Waid.
Keywords: hepatitis C; medical treatment method; patient; patient assessment; quality of life; emotional and psychiatric depression; Switzerland
|
|
|
Junet, C. (2009). Co-infection with HIV. In 1st International Symposium on Hepatitis care in substance users (39). Zurich: Centre de soins du Plateau.
Keywords: hepatitis C; HIV infection; addiction; AOD dependence; chemical addiction; medical treatment method
|
|
|
Kastelic, A. (2009). Different ways of approach : Eastern Europe. In 1st International Symposium on Hepatitis care in substance users (51). Zurich: Psychiatric Clinic Ljubljana, Center for Treatment of Drug Addiction.
Keywords: hepatitis C; addiction; AOD dependence; chemical addiction; drug user; illicit drug; harm reduction; treatment and maintenance; prison; Slovenia
|
|
|
Lindenburg, K. (2009). Hepatitis C testing and treatment among active drug users in Amsterdam : promising results of the Dutch-C project (drug users treatment for chronic hepatitis C). In 1st International Symposium on Hepatitis care in substance users (14). Zurich: Public Health Service of Amsterdam, Cluster Infectious Diseases, Research Department.
Keywords: hepatitis C; addiction; AOD use; AOD dependence; chemical addiction; drug user; medical treatment method; treatment outcome; Amsterdam
|
|
|
Matheï, C. (2009). Hepatitis C and protective immunity : a systematic review. In 1st International Symposium on Hepatitis care in substance users (35). Zurich: Katholieke Universiteit Leuven; Free Clinic.
Keywords: hepatitis C; addiction; AOD dependence; chemical addiction; drug user; illicit drug; infection
|
|
|
Melin, P. (2009). Vaccination : whom? when? against what? In 1st International Symposium on Hepatitis care in substance users (26). Zurich: SOS hépatites.
Keywords: hepatitis A; hepatitis B; hepatitis C; hepatitis E; HIV infection; vaccination; addiction; AOD dependence; chemical addiction; drug user; medical treatment method; Europe
|
|
|
Mousalli, J. (2009). Management of HCV infected IDUs in addiction centers. In 1st International Symposium on Hepatitis care in substance users (25). Zurich: Programme HépatiteC'Toxicomanie (Hep'Tox France).
Keywords: hepatitis C; addiction; AOD dependence; chemical addiction; drug user; illicit drug; medical treatment method; France
|
|
|
Müllhaupt, B. (2009). HBV/HCV coinfection. In 1st International Symposium on Hepatitis care in substance users (22). Zurich: Universitätsspital Zürich, Klinik für Gastroenterologie und Hepatologie.
Keywords: hepatitis B; hepatitis C; infection; medical treatment method
|
|
|
Randl, K. (2009). Is multi-disciplinary management sufficient to prompt intravenous drug users on opiate maintenance therapy to treat their chronic hepatitis C? In 1st International Symposium on Hepatitis care in substance users (24). Zurich: Hôtel-Dieu (Centre Hospitalier Universitaire de Clermont-Ferrand), Service d'Hépato-Gastroentérologie.
Keywords: hepatitis C; intravenous drug user; treatment and maintenance; medical treatment method; patient care management; France
|
|
|
Rehak, V., & Krekulova, L. (2009). IDU and HCV treatment : high response and low reinfection rate. In 1st International Symposium on Hepatitis care in substance users (21). Zurich: Remedis.
Keywords: hepatitis C; addiction; AOD dependence; chemical addiction; intravenous drug user; infection; Czech Republic
|
|